Search results for "Double blind study"

showing 8 items of 8 documents

Randomized, double-blind study comparing percutaneous electrolysis and dry needling for the management of temporomandibular myofascial pain

2018

Background To assess whether the techniques of percutaneous needle electrolysis (PNE) and deep dry needling (DDN) used on trigger points (TrP) of lateral pterygoid muscle (LPM) can significantly reduce pain and improve function in patients with myofascial pain syndrome (MPS) compared to a control group treated with a sham needling procedure (SNP). Material and Methods Sixty patients diagnosed with MPS in the LPM were selected and randomly assigned to one of three groups. The PNE group received electrolysis to the LPM via transcutaneous puncture. The DDN group received a deep puncture to the TrP without the introduction of any substance. In the SNP group, pressure was applied to the skin wit…

AdultMalePercutaneousAdolescentAcupuncture TherapyElectric Stimulation TherapyMyofascial pain syndromeLateral pterygoid muscleElectrolysislaw.inventionDouble blind studyYoung Adult03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawHumansMedicineAdverse effectMyofascial Pain SyndromesGeneral DentistryAged030222 orthopedicsDry needlingOral Medicine and Pathologybusiness.industryResearchMyofascial painTrigger PointsPterygoid Muscles030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOtorhinolaryngologyNeedlesSpainAnesthesiaUNESCO::CIENCIAS MÉDICASFemaleSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Effect of Corticosteroids on Facial Function after Cerebellopontine Angle Tumor Removal: A Double-Blind Study versus Placebo

2015

The aim of this study was to assess the effect of corticosteroids administered intra- and postoperatively on the occurrence of facial palsy after a cerebellopontine angle (CPA) tumor resection, and to investigate pre- and intraoperative prognostic factors. A multicenter, prospective, randomized, double-blind and versus-placebo study was conducted between 2006 and 2010. Three hundred and ten patients operated on for a CPA tumor (96% vestibular schwannomas, 4% miscellaneous) were included by five participating centers. The population was stratified into patients with small (≤15 mm CPA on axial MRI views) and large tumors. In each group, patients were randomized to receive corticosteroid (1 mg…

AdultMalemedicine.medical_specialtyAdolescentPhysiologymedicine.drug_classFacial ParalysisPopulationPlaceboMethylprednisoloneDouble blind studyYoung AdultSpeech and HearingPostoperative ComplicationsDouble-Blind MethodAdrenal Cortex HormonesmedicineHumanseducationGlucocorticoidsGrading (tumors)AgedAged 80 and overPostoperative Careeducation.field_of_studyIntraoperative CarePalsybusiness.industry[SCCO.NEUR]Cognitive science/NeuroscienceNeuroma AcousticMiddle AgedCerebellopontine anglemedicine.diseaseSensory SystemsFacial paralysisSurgeryOtorhinolaryngologyMethylprednisoloneCorticosteroidFemaleNeurology (clinical)Tumor removalbusinessmedicine.drug
researchProduct

Double-Blind Study on the Effects of Steroids on Severe Closed Head Injury

1976

The results of a double-blind study on the effects of a low dose and a high dose of dexamethasone on severe closed head injury are presented. The steroid, particularly in high dose, reduced mortality, improved the neurologic course and the final outcome. Timing of steroid administration is of great importance.

Double blind studySevere head injurybusiness.industryBrain edemaAnesthesiaClosed head injuryHead injuryLow doseMedicinebusinessmedicine.diseaseDexamethasonemedicine.drug
researchProduct

Randomized, Double-Blind Study of Sonidegib (Lde225) in Patients (Pts) with Advanced Basal Cell Carcinoma (Bcc)

2014

ABSTRACT Aim: The BOLT phase 2 study, comparing 2 doses of sonidegib, a hedgehog pathway inhibitor (HhPI), in pts with advanced BCC (aBCC; NCT01327053), met its primary endpoint of objective response rate ≥30% in both arms in analyses of data collected up to 6 mo after randomization of the last pt (June 28, 2013, cutoff; median follow-up [f/u], 13.9 mo; Migden, ASCO 2014). Associations of GLI1 (marker of Hh pathway activation) with clinical outcome (as of June 28, 2013) and updated 12-mo efficacy and safety data (Dec 31, 2013, cutoff; median f/u, 20.0 mo) are presented. Methods: Pts with locally advanced BCC (LaBCC; n = 194) not amenable to curative surgery or radiation or metastatic BCC (m…

Oncologymedicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationPhases of clinical researchHematologymedicine.diseaseSonidegibDouble blind studychemistry.chemical_compoundOncologychemistryInternal medicineClinical endpointMedicineIn patientBasal cell carcinomabusinesseducationProgressive diseaseAnnals of Oncology
researchProduct

Aceclofenac cream versus piroxicam cream in the treatment of patients with minor traumas and phlogistic affections of soft tissues: a double-blind st…

1995

Abstract The efficacy and safety of aceclofenac 1.5% cream and piroxicam 1% cream in 220 patients with soft-tissue injuries were evaluated in a double-blind, randomized, multicenter, comparative, parallel-group trial. Patients were randomly assigned to each treatment group to receive therapy three times a day for 7 days. The primary outcome measure of pain was evaluated using a visual analog scale (VAS) at baseline, day 4, and day 7 of the study. Safety was assessed by recording any adverse events that occurred and by monitoring any hemato-biochemical alterations during the study. After days 4 and 7 of treatment, a significant improvement ( P P

PharmacologyChemotherapymedicine.medical_specialtyRandomizationbusiness.industryVisual analogue scalemedicine.medical_treatmentSoft tissuePiroxicamSurgeryDouble blind studyAnesthesiaMedicineAceclofenacPharmacology (medical)businessAdverse effectmedicine.drugCurrent Therapeutic Research
researchProduct

evaluation of BNP plasma levels and bioelectrical impedance analysis (BIA) in decompensated heart failure. A double blind study

2005

medicine.medical_specialtyEjection fractionbusiness.industryFurosemidePlasma levelsmedicine.diseaseDouble blind studyFluid intakeHeart failureInternal medicineHeart rateInternal MedicineCardiologyMedicinebusinessBioelectrical impedance analysismedicine.drug
researchProduct

Analgosedierungsverfahren f�r zahn�rztlich-chirurgische Eingriffe mit Midazolam/Pentazocin und Midazolam/Ketamin Klinische Doppelblindstudie zu Anxio…

1995

Ketamin/Midazolam zur Analgosedierung erwies sich in bezug auf Kreislauf und Atmung gegenuber Pentazocin/Midazolam uberlegen [23]. Diese Studie sollte klaren, ob 0,25 oder 0,5 mg/kg KG Ketamin, 0,075 mg/kg KG Midazolam, unter den Aspekten Anxiolyse, Analgesie, Sedierung und Amnesie eine Alternative zu Pentazocin/Midazolam ist. Kontrollgruppe (KG): Lokalanasthesie (LA) mit Articain 4%/Adrenalinzusatz 1:200.000 (n=35); Testgruppe P/M: LA und 0,40 mg/kg KG Pentazocin/0,075 mg/kg KG Midazolam i.v. (n=35); Testgruppe K25/M: LA und 0,25 mg/kg KG Ketamin/0,075 mg/kg KG Midazolam i.v. (n=35); Testgruppe K50/M: LA und 0,50 mg/kg KG Ketamin/0,075 mg/kg KG Midazolam i.v. (n=35). Die LA wurde 3 min nac…

medicine.medical_specialtybusiness.industrySedationGeneral MedicinePentazocinSurgeryDouble blind studyAnesthesiology and Pain MedicinePentazocineFace surgeryAnesthesiamedicineMidazolamKetaminemedicine.symptombusinessmedicine.drugDer Anaesthesist
researchProduct

OP0015 Induction of remission and maintenance in early, aggressive rheumatoid arthritis using adalimumab in combination with methotrexate with or wit…

2017

Background Remission is the current aim of early RA treatment. In patients with early, aggressive RA, combination with adalimumab (ADA) plus methotrexate (MTX) was superior to either MTX or ADA alone in obtaining clinical remission. Moreover, it has been demonstrated that a short-term aggressive treatment with high-dose glucocorticoids (GC) plus conventional DMARDs lead to long-term (up to 5 years) benefits. Objectives To compare the proportion of patients who achieve remission at 12 months, between two groups of subjects treated with ADA + MTX + high dose GC (intensive) and ADA + MTX + placebo (standard), and to evaluate the proportion of those maintaining remission at 24 months, after dis…

musculoskeletal diseasesmedicine.medical_specialtybusiness.industry030503 health policy & servicesmedicine.diseasePlaceboGastroenterologyDiscontinuationFirst line treatmentDouble blind study03 medical and health sciences0302 clinical medicineimmune system diseasesPrednisoneRheumatoid arthritisInternal medicinemedicineAdalimumabMethotrexate030212 general & internal medicine0305 other medical sciencebusinessmedicine.drug
researchProduct